Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-07 3:31 pm Purchase | 2021-12-31 | 13G | SOS Limited SOS | Hudson Bay Capital Management LP | 346,350 9.990% | 346,350 (New Position) | Filing History |
| 2022-02-07 3:28 pm Purchase | 2021-12-31 | 13G | Pono Capital Corp. PONO | Hudson Bay Capital Management LP | 775,000 6.740% | 775,000 (New Position) | Filing History |
| 2022-02-07 3:26 pm Purchase | 2021-12-31 | 13G | OCEANTECH ACQUISITIONS I CORP OTAC | Hudson Bay Capital Management LP | 990,000 9.490% | 990,000 (New Position) | Filing History |
| 2022-02-07 3:24 pm Purchase | 2021-12-31 | 13G | Disruptive Acquisition Corporation I DISA | Hudson Bay Capital Management LP | 2,025,615 7.370% | 2,025,615 (New Position) | Filing History |
| 2022-02-07 3:22 pm Purchase | 2021-12-31 | 13G | Data Knights Acquisition Corp. DKDCA | Hudson Bay Capital Management LP | 949,974 7.860% | 949,974 (New Position) | Filing History |
| 2022-02-07 3:17 pm Unchanged | 2021-12-31 | 13G | Aptorum Group Limited APM | Hudson Bay Capital Management LP | 92,308 6.540% | 0 (Unchanged) | Filing History |
| 2022-02-07 3:07 pm Purchase | 2021-12-31 | 13G | Aesther Healthcare Acquisition Corp. AEHA | Hudson Bay Capital Management LP | 600,000 5.660% | 600,000 (New Position) | Filing History |
| 2022-02-04 4:29 pm Sale | 2021-12-31 | 13G | Protagenic Therapeutics, Inc. PTIX | Hudson Bay Capital Management LP | 0 0.000% | -19,517 (Position Closed) | Filing History |
| 2022-02-04 4:26 pm Sale | 2021-12-31 | 13G | Cosmos Health Inc. COSM | Hudson Bay Capital Management LP | 34,337 4.720% | -6,047 (-14.97%) | Filing History |
| 2022-02-04 4:23 pm Purchase | 2021-12-31 | 13G | Synthetic Biologics, Inc. SYN | Hudson Bay Capital Management LP | 260,870 1.940% | 38,968 (+17.56%) | Filing History |
| 2022-02-04 4:19 pm Unchanged | 2021-12-31 | 13G | Peraso Inc. PRSO | Hudson Bay Capital Management LP | 0 0.000% | 0 (Unchanged) | Filing History |
| 2022-02-04 4:17 pm Purchase | 2021-12-31 | 13G | Viveve Medical, Inc. VIVE | Hudson Bay Capital Management LP | 258,064 2.380% | 17,075 (+7.09%) | Filing History |
| 2022-02-04 4:15 pm Unchanged | 2021-12-31 | 13G | Tenax Therapeutics, Inc. TENX | Hudson Bay Capital Management LP | 486 2.990% | 0 (Unchanged) | Filing History |
| 2022-02-04 4:10 pm Purchase | 2021-12-31 | 13G | Plus Therapeutics, Inc. PSTV | Hudson Bay Capital Management LP | 36,667 3.460% | 1,302 (+3.68%) | Filing History |
| 2022-02-04 4:08 pm Purchase | 2021-12-31 | 13G | LM Funding America, Inc. LMFA | Hudson Bay Capital Management LP | 30,000 1.390% | 30,000 (New Position) | Filing History |
| 2022-02-04 4:06 pm Unchanged | 2021-12-31 | 13G | Helbiz, Inc. HLBZ | Hudson Bay Capital Management LP | 0 0.000% | 0 (Unchanged) | Filing History |
| 2022-02-04 4:03 pm Unchanged | 2021-12-31 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | Hudson Bay Capital Management LP | 115 3.970% | 0 (Unchanged) | Filing History |
| 2022-02-04 3:59 pm Unchanged | 2021-12-31 | 13G | Can-Fite BioPharma Ltd. CANF | Hudson Bay Capital Management LP | 121,921 4.080% | 0 (Unchanged) | Filing History |
| 2022-02-04 3:56 pm Unchanged | 2021-12-31 | 13G | Arcadia Biosciences, Inc. RKDA | Hudson Bay Capital Management LP | 22,251 3.860% | 0 (Unchanged) | Filing History |
| 2022-02-04 3:42 pm Sale | 2021-12-31 | 13G | Yield10 Bioscience, Inc. YTEN | Hudson Bay Capital Management LP | 417 0.200% | -9,479 (-95.79%) | Filing History |